{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T09:40:19Z","timestamp":1783244419864,"version":"3.54.6"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["92059204"],"award-info":[{"award-number":["92059204"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273419"],"award-info":[{"award-number":["82273419"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2022YFA1205003"],"award-info":[{"award-number":["2022YFA1205003"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.canlet.2026.218280","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T17:02:23Z","timestamp":1769101343000},"page":"218280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Dysregulation of the ALDH1A3\/PML\u2013RAR\u03b1 axis promotes the progression of acute promyelocytic leukemia"],"prefix":"10.1016","volume":"642","author":[{"given":"Jiao","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Hui","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Ping","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Ying","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang-Jie","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cai","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Cang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.canlet.2026.218280_bib1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41408-021-00514-3","article-title":"F. R. Acute promyelocytic leukemia current treatment algorithms","volume":"11","author":"Yilmaz","year":"2021","journal-title":"Blood Cancer J."},{"issue":"2","key":"10.1016\/j.canlet.2026.218280_bib2","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1182\/blood.2024026186","article-title":"Acute promyelocytic leukemia: long-term outcomes from the HARMONY project","volume":"145","author":"Voso","year":"2025","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.canlet.2026.218280_bib3","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S1470-2045(18)30295-X","article-title":"Oral arsenic plus retinoic acid versus intravenous arsenic plus retinoic acid for non-high-risk acute promyelocytic leukaemia: a non-inferiority, randomised phase 3 trial","volume":"19","author":"Zhu","year":"2018","journal-title":"Lancet Oncol."},{"issue":"5","key":"10.1016\/j.canlet.2026.218280_bib4","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ccell.2017.10.002","article-title":"Z. C. Acute promyelocytic leukemia: a paradigm for oncoprotein-targeted cure","volume":"32","author":"de Th\u00e9","year":"2017","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.canlet.2026.218280_bib5","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2020382118","article-title":"Arsenic trioxide replacing or reducing chemotherapy in consolidation therapy for acute promyelocytic leukemia (APL2012 trial)","volume":"118","author":"Chen","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.canlet.2026.218280_bib6","article-title":"Acute promyelocytic leukemia, retinoic acid, and arsenic: a tale of dualities","volume":"14","author":"R\u00e9rolle","year":"2024","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"29","key":"10.1016\/j.canlet.2026.218280_bib7","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1200\/JCO-25-00535","article-title":"Arsenic trioxide and all-trans retinoic acid combination therapy for the treatment of high-risk acute promyelocytic leukemia: results from the APOLLO trial","volume":"43","author":"Platzbecker","year":"2025","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.canlet.2026.218280_bib8","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1182\/bloodadvances.2024014999","article-title":"Acute Promyelocytic Leukemia Asian Consortium study of arsenic trioxide in newly diagnosed patients: impact and outcome","volume":"9","author":"Gill","year":"2025","journal-title":"Blood Adv."},{"issue":"15","key":"10.1016\/j.canlet.2026.218280_bib9","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1182\/blood-2019-01-894980","article-title":"Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European Leukemia Net","volume":"133","author":"Sanz","year":"2019","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.canlet.2026.218280_bib10","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/s41418-023-01139-8","article-title":"Targeting HDAC3 to overcome the resistance to ATRA or arsenic in acute promyelocytic leukemia through ubiquitination and degradation of PML-RAR\u03b1","volume":"30","author":"Dai","year":"2023","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.canlet.2026.218280_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108481","article-title":"Vitamin A and retinoid signaling in the kidneys","volume":"248","author":"DiKun","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.canlet.2026.218280_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1254612","article-title":"Targeting the retinoic acid signaling pathway as a modern precision therapy against cancers","volume":"11","author":"Lavudi","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"issue":"10","key":"10.1016\/j.canlet.2026.218280_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/hem3.70244","article-title":"Upregulation of ALDH1 as an adaptive epigenetic response to anthracyclines in acute myeloid leukemia","volume":"9","author":"Leonetti","year":"2025","journal-title":"HemaSphere"},{"issue":"11","key":"10.1016\/j.canlet.2026.218280_bib14","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1038\/s41375-025-02738-9","article-title":"PML::RAR\u03b1+ myeloid cells display metabolic alterations that can be targeted to treat resistant\/relapse acute promyelocytic leukemias","volume":"39","author":"Zaza","year":"2025","journal-title":"Leukemia"},{"issue":"26","key":"10.1016\/j.canlet.2026.218280_bib15","doi-asserted-by":"crossref","first-page":"11950","DOI":"10.7150\/thno.49717","article-title":"Gastric cancer mesenchymal stem cells regulate PD-L1-CTCF enhancing cancer stem cell-like properties and tumorigenesis","volume":"10","author":"Sun","year":"2020","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.canlet.2026.218280_bib16","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1038\/s41467-023-38097-1","article-title":"KK-LC-1 as a therapeutic target to eliminate ALDH(+) stem cells in triple negative breast cancer","volume":"14","author":"Bu","year":"2023","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.canlet.2026.218280_bib17","doi-asserted-by":"crossref","first-page":"714","DOI":"10.7150\/thno.88057","article-title":"ALDH1A1 drives prostate cancer metastases and radioresistance by interplay with AR- and RAR-dependent transcription","volume":"14","author":"Gorodetska","year":"2024","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.canlet.2026.218280_bib18","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12943-023-01877-w","article-title":"Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer","volume":"22","author":"Zeng","year":"2023","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2026.218280_bib19","doi-asserted-by":"crossref","first-page":"9417","DOI":"10.1038\/s41467-024-53771-8","article-title":"Self-assembled aldehyde dehydrogenase-activatable nano-prodrug for cancer stem cell-enriched tumor detection and treatment","volume":"15","author":"Li","year":"2024","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.canlet.2026.218280_bib20","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/ijc.29410","article-title":"The rarity of ALDH(+) cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patients","volume":"137","author":"Hoang","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"9","key":"10.1016\/j.canlet.2026.218280_bib21","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.3324\/haematol.2016.163584","article-title":"Reduced hematopoietic stem cell frequency predicts outcome in acute myeloid leukemia","volume":"102","author":"Wang","year":"2017","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.canlet.2026.218280_bib22","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/sj.leu.2404721","article-title":"Aldehyde dehydrogenase activity in leukemic blasts defines a subgroup of acute myeloid leukemia with adverse prognosis and superior NOD\/SCID engrafting potential","volume":"21","author":"Cheung","year":"2007","journal-title":"Leukemia"},{"issue":"13","key":"10.1016\/j.canlet.2026.218280_bib23","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.1158\/1078-0432.CCR-20-4375","article-title":"Integration of genomic and transcriptomic markers improves the prognosis prediction of acute promyelocytic leukemia","volume":"27","author":"Lin","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.canlet.2026.218280_bib24","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13073-025-01565-y","article-title":"Disease-specific epigenetic deregulation of enhancers, transposons, and polycomb targets in acute promyelocytic leukemia","volume":"17","author":"Zhong","year":"2025","journal-title":"Genome Med."},{"issue":"1","key":"10.1016\/j.canlet.2026.218280_bib25","doi-asserted-by":"crossref","first-page":"5570","DOI":"10.1038\/s41467-024-49784-y","article-title":"Epigenetic-based differentiation therapy for Acute Myeloid Leukemia","volume":"15","author":"San Jos\u00e9-En\u00e9riz","year":"2024","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.canlet.2026.218280_bib26","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1182\/blood.2020005698","article-title":"A PML\/RAR\u03b1 direct target atlas redefines transcriptional deregulation in acute promyelocytic leukemia","volume":"137","author":"Tan","year":"2021","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.canlet.2026.218280_bib27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41593-018-0285-z","article-title":"Invasion of white matter tracts by glioma stem cells is regulated by a NOTCH1-SOX2 positive-feedback loop","volume":"22","author":"Wang","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.canlet.2026.218280_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215662","article-title":"An aldehyde dehydrogenase 1A3 inhibitor attenuates the metastasis of human colorectal cancer","volume":"536","author":"Duan","year":"2022","journal-title":"Cancer Lett."},{"issue":"10","key":"10.1016\/j.canlet.2026.218280_bib29","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/cac2.12349","article-title":"PLEK2 promotes cancer stemness and tumorigenesis of head and neck squamous cell carcinoma via the c-Myc-mediated positive feedback loop","volume":"42","author":"Zhao","year":"2022","journal-title":"Cancer Commun."},{"issue":"1","key":"10.1016\/j.canlet.2026.218280_bib30","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12943-024-02129-1","article-title":"PBA2, a novel inhibitor of the \u03b2-catenin\/CBP pathway, eradicates chronic myeloid leukemia including BCR-ABL T315I mutation","volume":"23","author":"Yang","year":"2024","journal-title":"Mol. Cancer"},{"issue":"531","key":"10.1016\/j.canlet.2026.218280_bib31","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax8694","article-title":"Inhibition of the ALDH18A1-MYCN positive feedback loop attenuates MYCN-amplified neuroblastoma growth","volume":"12","author":"Guo","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.canlet.2026.218280_bib32","article-title":"Driver mutation landscape of acute myeloid leukemia provides insights for neoantigen-based immunotherapy","volume":"611","author":"Jin","year":"2024","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.canlet.2026.218280_bib33","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1365-2141.2008.07261.x","article-title":"An international standardization programme towards the application of gene expression profiling in routine leukaemia diagnostics: the Microarray Innovations in Leukemia study prephase","volume":"142","author":"Kohlmann","year":"2008","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.canlet.2026.218280_bib34","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1001\/jamaoncol.2024.7033","article-title":"Academic community partnership in acute promyelocytic leukemia and early mortality: the ECOG-ACRIN EA9131 trial","volume":"11","author":"Jillella","year":"2025","journal-title":"JAMA Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218280_bib35","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2023.2166035","article-title":"ALDEFLUOR activity, ALDH isoforms, and their clinical significance in cancers","volume":"38","author":"Duan","year":"2023","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"13","key":"10.1016\/j.canlet.2026.218280_bib36","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1084\/jem.20131121","article-title":"PP. P. Synergy against PML-RARa: targeting transcription, proteolysis, differentiation, and self-renewal in acute promyelocytic leukemia","volume":"210","author":"Dos Santos","year":"2013","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.canlet.2026.218280_bib37","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41401-024-01371-z","article-title":"Palmitoyltransferase ZDHHC3 is essential for the oncogenic activity of PML\/RAR\u03b1 in acute promyelocytic leukemia","volume":"46","author":"Shao","year":"2025","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.canlet.2026.218280_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-022-01695-6","article-title":"MicroRNA-1 attenuates the growth and metastasis of small cell lung cancer through CXCR4\/FOXM1\/RRM2 axis","volume":"22","author":"Khan","year":"2023","journal-title":"Mol. Cancer"},{"issue":"12","key":"10.1016\/j.canlet.2026.218280_bib39","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1158\/2159-8290.CD-23-0453","article-title":"Structural basis of PML-RARA oncoprotein targeting by Arsenic Unravels a cysteine rheostat controlling PML body assembly and function","volume":"13","author":"Bercier","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2026.218280_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153444","article-title":"Saikosaponin a contributed to CCIN treatment by promoting neutrophil bactericidal activity via activation CBL-dependent ERK pathway","volume":"82","author":"Qi","year":"2021","journal-title":"Phytomedicine"},{"issue":"4","key":"10.1016\/j.canlet.2026.218280_bib41","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s41375-025-02530-9","article-title":"Distinct leukemogenic mechanism of acute promyelocytic leukemia based on genomic structure of PML::RAR\u03b1","volume":"39","author":"Minami","year":"2025","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.canlet.2026.218280_bib42","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/ajco.13748","article-title":"X. Z. Roles of Myc-associated zinc finger protein in malignant tumors","volume":"18","author":"Zheng","year":"2022","journal-title":"Asia Pac. J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.canlet.2026.218280_bib43","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s41419-024-06835-y","article-title":"MAZ-mediated up-regulation of BCKDK reprograms glucose metabolism and promotes growth by regulating glucose-6-phosphate dehydrogenase stability in triple-negative breast cancer","volume":"15","author":"Li","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2026.218280_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217201","article-title":"MAZ promotes thyroid cancer progression by driving transcriptional reprogram and enhancing ERK1\/2 activation","volume":"602","author":"Zeng","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218280_bib45","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.canlet.2017.05.020","article-title":"Dual function of MAZ mediated by FOXF2 in basal-like breast cancer: promotion of proliferation and suppression of progression","volume":"402","author":"Yu","year":"2017","journal-title":"Cancer Lett."},{"issue":"21","key":"10.1016\/j.canlet.2026.218280_bib46","doi-asserted-by":"crossref","first-page":"8792","DOI":"10.1158\/0008-5472.CAN-08-4481","article-title":"PML-RAR{alpha} and Dnmt3a1 cooperate in vivo to promote acute promyelocytic leukemia","volume":"70","author":"Subramanyam","year":"2010","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.canlet.2026.218280_bib47","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1172\/JCI82897","article-title":"PML-RARA requires DNA methyltransferase 3A to initiate acute promyelocytic leukemia","volume":"126","author":"Cole","year":"2016","journal-title":"J. Clin. Investig."},{"issue":"5557","key":"10.1016\/j.canlet.2026.218280_bib48","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1126\/science.1065173","article-title":"Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor","volume":"295","author":"Di Croce","year":"2002","journal-title":"Science"},{"issue":"6669","key":"10.1016\/j.canlet.2026.218280_bib49","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/35895","article-title":"RM. E. Role of the histone deacetylase complex in acute promyelocytic leukaemia","volume":"391","author":"Lin","year":"1998","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.canlet.2026.218280_bib50","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1073\/pnas.0509343103","article-title":"The methyl-CpG binding protein MBD1 is required for PML-RARalpha function","volume":"103","author":"Villa","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.canlet.2026.218280_bib51","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s43018-021-00213-9","article-title":"Hotspot DNMT3A mutations in clonal hematopoiesis and acute myeloid leukemia sensitize cells to azacytidine via viral mimicry response","volume":"2","author":"Scheller","year":"2021","journal-title":"Nat. Cancer"},{"issue":"10","key":"10.1016\/j.canlet.2026.218280_bib52","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1038\/s41588-022-01179-9","article-title":"Single-cell multi-omics of human clonal hematopoiesis reveals that DNMT3A R882 mutations perturb early progenitor states through selective hypomethylation","volume":"54","author":"Nam","year":"2022","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.canlet.2026.218280_bib53","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40364-021-00284-x","article-title":"J. J. Current views on the genetic landscape and management of variant acute promyelocytic leukemia","volume":"9","author":"Zhang","year":"2021","journal-title":"Biomark. Res."},{"key":"10.1016\/j.canlet.2026.218280_bib54","article-title":"Clinical response to venetoclax and decitabine in acute promyelocytic leukemia with a novel RARA-THRAP3 fusion: a case report","volume":"12","author":"Song","year":"2022","journal-title":"Front. Oncol."},{"issue":"43","key":"10.1016\/j.canlet.2026.218280_bib55","article-title":"Does acute promyelocytic leukemia patient with the STAT5B\/RARa fusion gene respond well to decitabine?: a case report and literature review","volume":"99","author":"Wang","year":"2020","journal-title":"Medicine (Baltim.)"},{"issue":"11","key":"10.1016\/j.canlet.2026.218280_bib56","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/nrd1551","article-title":"V. L. Principles for modulation of the nuclear receptor superfamily","volume":"3","author":"Gronemeyer","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.canlet.2026.218280_bib57","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s41467-023-36262-0","article-title":"Multi-omics and machine learning reveal context-specific gene regulatory activities of PML::RARA in acute promyelocytic leukemia","volume":"14","author":"Villiers","year":"2023","journal-title":"Nat. Commun."},{"issue":"18","key":"10.1016\/j.canlet.2026.218280_bib58","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1161\/CIRCULATIONAHA.124.071954","article-title":"Aortic valve calcification is induced by the loss of ALDH1A1 and can be prevented by agonists of retinoic acid receptor alpha: preclinical evidence for drug repositioning","volume":"151","author":"Rosa","year":"2025","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.canlet.2026.218280_bib59","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1182\/blood-2010-01-261040","article-title":"Autophagy contributes to therapy-induced degradation of the PML\/RARA oncoprotein","volume":"116","author":"Isakson","year":"2010","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.canlet.2026.218280_bib60","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.3390\/ijms20143559","article-title":"Autophagy: new insights into mechanisms of action and resistance of treatment in acute promyelocytic leukemia","volume":"20","author":"Moosavi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.canlet.2026.218280_bib61","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/annonc\/mdw660","article-title":"Network-guided modeling allows tumor-type independent prediction of sensitivity to all-trans-retinoic acid","volume":"28","author":"Bolis","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2026.218280_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116779","article-title":"Halogenated retinoid derivatives as dual RAR\u03b1 and RXR\u03b1 modulators for treating acute promyelocytic leukemia cells","volume":"277","author":"Xu","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.canlet.2026.218280_bib63","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S1097-2765(01)00257-X","article-title":"Role of PML and PML-RARalpha in Mad-mediated transcriptional repression","volume":"7","author":"Khan","year":"2001","journal-title":"Mol. Cell"},{"issue":"22","key":"10.1016\/j.canlet.2026.218280_bib64","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia","volume":"368","author":"Network","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.canlet.2026.218280_bib65","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13045-023-01424-6","article-title":"C. L. Recent advances in targeted therapies in acute myeloid leukemia","volume":"16","author":"Bhansali","year":"2023","journal-title":"J. Hematol. Oncol."},{"issue":"7935","key":"10.1016\/j.canlet.2026.218280_bib66","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41586-022-05365-x","article-title":"Subtype-specific 3D genome alteration in acute myeloid leukaemia","volume":"611","author":"Xu","year":"2022","journal-title":"Nature"},{"issue":"Suppl 1","key":"10.1016\/j.canlet.2026.218280_bib67","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.ctrv.2011.04.013","article-title":"C. M-T. DNA methylation as a pathogenic event and as a therapeutic target in AML","volume":"37","author":"Schoofs","year":"2011","journal-title":"Cancer Treat Rev."},{"issue":"1","key":"10.1016\/j.canlet.2026.218280_bib68","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1182\/blood-2012-08-448860","article-title":"DNA methylation changes are a late event in acute promyelocytic leukemia and coincide with loss of transcription factor binding","volume":"121","author":"Schoofs","year":"2013","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.canlet.2026.218280_bib69","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/ajh.25369","article-title":"V. P. Hypomethylating agents in combination with venetoclax for acute myeloid leukemia: update on clinical trial data and practical considerations for use","volume":"94","author":"Mei","year":"2019","journal-title":"Am. J. Hematol."},{"issue":"12","key":"10.1016\/j.canlet.2026.218280_bib70","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1038\/s41375-019-0612-8","article-title":"How we use venetoclax with hypomethylating agents for the treatment of newly diagnosed patients with acute myeloid leukemia","volume":"33","author":"Jonas","year":"2019","journal-title":"Leukemia"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526000431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526000431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T07:59:13Z","timestamp":1773993553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526000431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":70,"alternative-id":["S0304383526000431"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218280","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dysregulation of the ALDH1A3\/PML\u2013RAR\u03b1 axis promotes the progression of acute promyelocytic leukemia","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218280","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"218280"}}